Skip to main content
Premium Trial:

Request an Annual Quote

NCI Awards Insightful $1.4M in Contracts to Develop Proteomic Software

NEW YORK, May 16 (GenomeWeb News) - Statistical software developer Insightful said today that the National Cancer Institute has awarded it two Phase II contracts worth $1,394,027 to develop proteomics software.

 

Under the terms of the two-year contracts, Insightful will develop software for identifying protein biomarkers and will also develop a product called S+Proteome for processing and analyzing protein mass spectral data.

 

The awards follow on two preliminary software-development contracts worth $186,000 that NCI awarded Insightful in February.

 

S+Proteome will be built upon Insightful's S-Plus and S+ArrayAnalyzer software products.

 

As part of the phase II contracts, Insightful said it will also write a book on the analysis of mass spectra data using S-Plus and S+Proteome.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.